Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 18, 2019 - Issue 11
Submit an article Journal homepage
412
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey

Hideki SanoCNS Medical Information, Medical Affairs, MSD K.K., Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1964-5824View further author information
ORCID Icon,
Yuko AsaiPharmacovigilance, MSD K.K., Tokyo, JapanView further author information
,
Makoto MiyazakiPharmacovigilance, MSD K.K., Tokyo, JapanView further author information
,
Mika IwakuraPharmacovigilance, MSD K.K., Tokyo, JapanView further author information
,
Yoshikazu MaedaPharmacovigilance, MSD K.K., Tokyo, JapanView further author information
&
Mitsuyoshi HaraPharmacovigilance, MSD K.K., Tokyo, JapanView further author information
Pages 1109-1118 | Received 16 May 2019, Accepted 14 Aug 2019, Published online: 03 Sep 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria P Mogavero, Alessandro Silvani, Giuseppe Lanza, Lourdes M DelRosso, Luigi Ferini-Strambi & Raffaele Ferri. (2023) Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations. Nature and Science of Sleep 15, pages 17-38.
Read now

Articles from other publishers (2)

Shoki Okuda, Zaina P. Qureshi, Yukiko Yanagida, Chie Ito, Yuji Homma & Shigeru Tokita. (2023) Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database. Drugs - Real World Outcomes 10:2, pages 271-281.
Crossref
Andrew H. Han, Caroline R. Burroughs, Evan P. Falgoust, Jamal Hasoon, Grace Hunt, Juyeon Kakazu, Tim Lee, Adam M. Kaye, Alan D. Kaye & Latha Ganti. (2023) Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia. Health Psychology Research 10:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.